SCHEMBL16633231

SCHEMBL16633231

N#Cc1cccc(NCCCCCl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.43
ALDH1A1 P00352 4/20 0.43
MAPT P10636 3/20 0.43
NOS1 P29475 1/20 0.42
IDO1 P14902 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CDC7 O00311 1/20 0.42
SYK P43405 1/20 0.42
LMNA P02545 1/20 0.41
ICMT O60725 1/20 0.41
KCNA5 P22460 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11113276 0.95 GRM4 (0.44) GRM4ALDH1A1MAPTNOS1IDO1
SCHEMBL5712396 0.90 ALDH1A1 (0.47) ALDH1A1MAPTNOS1IDO1MEN1
SCHEMBL16633472 0.84 ALDH1A1 (0.49) ALDH1A1MAPTNOS1IDO1MEN1
SCHEMBL28133362 0.84 ABL1 (0.44) ALDH1A1MAPTNOS1IDO1MEN1
SCHEMBL11115631 0.83 ALDH1A1 (0.59) GRM4ALDH1A1MAPTNOS1IDO1
SCHEMBL3476587 0.83 ABL1 (0.47) ALDH1A1MAPTNOS1IDO1MEN1
SCHEMBL11114890 0.82 ALDH1A1 (0.47) ALDH1A1MAPTNOS1IDO1MEN1
SCHEMBL14155105 0.82 TLR8 (0.47) ALDH1A1MAPTNOS1IDO1MEN1
SCHEMBL27301684 0.82 GABRG2 (0.41) GRM4ALDH1A1MAPTNOS1IDO1
SCHEMBL10019234 0.78 ALDH1A1 (0.50) GRM4ALDH1A1MAPTNOS1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238632-B2 3-cyanoanilinoalkylarylpiperazine derivative and use thereof in preparing drugs NHWA Pharma, Corporation (CN) 2016-01-19 US disclosed
US-20150105399-A1 3-CYANOANILINOALKYLARYLPIPERAZINE DERIVATIVE AND USE THEREOF IN PREPARING DRUGS SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105399-A1 3-CYANOANILINOALKYLARYLPIPERAZINE DERIVATIVE AND USE THEREOF IN PREPARING DRUGS HTR5A, HTR3C, HTR3A GRM4 609/4885ALDH1A1 670/4885MAPT 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.